Commerce, CA, United States of America

David N Wong

This inventor holds 34 USPTO granted patents and 10 published patent applications and 2 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Broadcom Corporation, The Nielsen Comapny (US), LLC, Humanscale Corporation. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David N Wong. Retrieved from https://idiyas.com/inventor/david-n-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 52.9

 

Average Co-Inventor Count = 2.2

ph-index = 9

Forward Citations = 536(Granted Patents)


Location History:

  • Commerce, CA (US) (2003)
  • Campbell, CA (US) (2002 - 2012)
  • Hollywood, FL (US) (1999 - 2014)
  • Milpitas, CA (US) (2006 - 2016)
  • New York, NY (US) (2015 - 2024)

Company Filing History:


Years Active: 1999-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Load Balancing
Error Compensation
HMG-CoA Reductase Inhibitor
Oral Solid Composition
Injectable Particle
Crossbar Leveling Adjustment
Audience Duplication
Analgesic Tablet
Management Information Base
Network Clients
Rate Adaptation
34 patents (USPTO):Explore Patents

Title: David N Wong: Pioneering Innovations in Pharmaceutical Patents

Introduction: David N Wong, based in Commerce, CA, is a prolific inventor with an impressive portfolio of 25 patents. His contributions to pharmaceutical formulations and innovative cancer therapies have made a significant impact in the field of medicine.

Latest Patents: Some of Wong's latest patents are particularly noteworthy. One such patent focuses on acamprosate formulations, which includes methods of using these formulations in combination with other medications, such as neuroleptic (antipsychotic) and antidepressant drugs. This invention pertains to the development of effective treatment options for patients by leveraging the synergistic effects of combined therapies. Another significant patent is for an injectable particle comprising dasatinib acetate and hyaluronic acid. This formulation is aimed at cancer therapy and incorporates unique elements, such as acetylated or sulfated hyaluronic acid and evenly dispersed acid in the matrix of the injectable particle, for enhanced therapeutic efficacy.

Career Highlights: David N Wong has leveraged his expertise in various prestigious companies, including Broadcom Corporation, where he has contributed to groundbreaking innovations. His work has consistently bridged the gap between scientific research and practical applications in medicine, showcasing his dedication to improving patient outcomes.

Collaborations: Throughout his career, Wong has collaborated with esteemed colleagues, including Chih-Ming Chen and Joseph C Chou. These partnerships have further enriched his innovative endeavors, leading to the development of advanced therapeutic solutions.

Conclusion: David N Wong stands out as a remarkable inventor in the pharmaceutical industry. His dedication to innovation and collaboration has resulted in influential patents that benefit both healthcare providers and patients. As he continues to explore new frontiers in medicine, Wong's work serves as an inspiration for future inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…